Literature DB >> 10923105

Managing the neurotoxicity of paclitaxel (Taxol) and docetaxel (Taxotere) with neurotrophic factors.

S C Apfel1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10923105     DOI： 10.3109/07357900009012196

Source DB:  PubMed          Journal:  Cancer Invest        ISSN： 0735-7907            Impact factor:   2.176


× No keyword cloud information.
  3 in total

Review 1.  Chemotherapy-induced peripheral neuropathy: pathogenesis and emerging therapies.

Authors:  Allyson J Ocean; Linda T Vahdat
Journal:  Support Care Cancer       Date:  2004-09       Impact factor: 3.603

2.  Phase I study of paclitaxel with standard dose ifosfamide in children with refractory solid tumors: a Pediatric Oncology Group study (POG 9376).

Authors:  James I Geller; Donna Wall; John Perentesis; Susan M Blaney; Mark Bernstein
Journal:  Pediatr Blood Cancer       Date:  2009-03       Impact factor: 3.167

3.  The neuroprotective effect of erythropoietin in docetaxel-induced peripheral neuropathy causes no reduction of antitumor activity in 13762 adenocarcinoma-bearing rats.

Authors:  Ilaria Cervellini; Ezia Bello; Roberta Frapolli; Carla Porretta-Serapiglia; Norberto Oggioni; Annalisa Canta; Raffaella Lombardi; Francesca Camozzi; Ilaria Roglio; Roberto Cosimo Melcangi; Maurizio D'incalci; Giuseppe Lauria; Pietro Ghezzi; Guido Cavaletti; Roberto Bianchi
Journal:  Neurotox Res       Date:  2009-10-30       Impact factor: 3.911
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.